Cargando…

Discovery of a Series of Theophylline Derivatives Containing 1,2,3-Triazole for Treatment of Non-Small Cell Lung Cancer

Chemotherapy is the most common clinical treatment for non-small cell lung cancer (NSCLC), but low efficiency and high toxicity of current chemotherapy drugs limit their clinical application. Therefore, it is urgent to develop hypotoxic and efficient chemotherapy drugs. Theophylline, a natural compo...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Jiahui, Mao, Longfei, Xie, Luoyijun, Zhang, Rongjun, Liu, Yulin, Peng, Lizeng, Yang, Jianxue, Li, Qingjiao, Yuan, Miaomiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8576520/
https://www.ncbi.nlm.nih.gov/pubmed/34764872
http://dx.doi.org/10.3389/fphar.2021.753676
_version_ 1784595892237500416
author Ye, Jiahui
Mao, Longfei
Xie, Luoyijun
Zhang, Rongjun
Liu, Yulin
Peng, Lizeng
Yang, Jianxue
Li, Qingjiao
Yuan, Miaomiao
author_facet Ye, Jiahui
Mao, Longfei
Xie, Luoyijun
Zhang, Rongjun
Liu, Yulin
Peng, Lizeng
Yang, Jianxue
Li, Qingjiao
Yuan, Miaomiao
author_sort Ye, Jiahui
collection PubMed
description Chemotherapy is the most common clinical treatment for non-small cell lung cancer (NSCLC), but low efficiency and high toxicity of current chemotherapy drugs limit their clinical application. Therefore, it is urgent to develop hypotoxic and efficient chemotherapy drugs. Theophylline, a natural compound, is safe and easy to get, and it can be used as a modified scaffold structure and hold huge potential for developing safe and efficient antitumor drugs. Herein, we linked theophylline with different azide compounds to synthesize a new type of 1,2,3-triazole ring-containing theophylline derivatives. We found that some theophylline1,2,3-triazole compounds showed a good tumor-suppressive efficacy. Especially, derivative d17 showed strong antiproliferative activity against a variety of cancer cells in vitro, including H460, A549, A2780, LOVO, MB-231, MCF-7, OVCAR3, SW480, and PC-9. It is worth noting that the two NSCLC cell lines H460 H and A549 are sensitive to compound d17 particularly, with IC50 of 5.929 ± 0.97 μM and 6.76 ± 0.25 μM, respectively. Compound d17 can significantly induce cell apoptosis by increasing the ratio of apoptotic protein Bax/Bcl-2 by downregulating the expression of phosphorylated Akt protein, and it has little toxicity to normal hepatocyte cells LO2 at therapeutic concentrations. These data indicate that these theophylline acetic acid-1,2,3-triazole derivatives may be potential drug candidates for anti-NSCLC and are worthy of further study.
format Online
Article
Text
id pubmed-8576520
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-85765202021-11-10 Discovery of a Series of Theophylline Derivatives Containing 1,2,3-Triazole for Treatment of Non-Small Cell Lung Cancer Ye, Jiahui Mao, Longfei Xie, Luoyijun Zhang, Rongjun Liu, Yulin Peng, Lizeng Yang, Jianxue Li, Qingjiao Yuan, Miaomiao Front Pharmacol Pharmacology Chemotherapy is the most common clinical treatment for non-small cell lung cancer (NSCLC), but low efficiency and high toxicity of current chemotherapy drugs limit their clinical application. Therefore, it is urgent to develop hypotoxic and efficient chemotherapy drugs. Theophylline, a natural compound, is safe and easy to get, and it can be used as a modified scaffold structure and hold huge potential for developing safe and efficient antitumor drugs. Herein, we linked theophylline with different azide compounds to synthesize a new type of 1,2,3-triazole ring-containing theophylline derivatives. We found that some theophylline1,2,3-triazole compounds showed a good tumor-suppressive efficacy. Especially, derivative d17 showed strong antiproliferative activity against a variety of cancer cells in vitro, including H460, A549, A2780, LOVO, MB-231, MCF-7, OVCAR3, SW480, and PC-9. It is worth noting that the two NSCLC cell lines H460 H and A549 are sensitive to compound d17 particularly, with IC50 of 5.929 ± 0.97 μM and 6.76 ± 0.25 μM, respectively. Compound d17 can significantly induce cell apoptosis by increasing the ratio of apoptotic protein Bax/Bcl-2 by downregulating the expression of phosphorylated Akt protein, and it has little toxicity to normal hepatocyte cells LO2 at therapeutic concentrations. These data indicate that these theophylline acetic acid-1,2,3-triazole derivatives may be potential drug candidates for anti-NSCLC and are worthy of further study. Frontiers Media S.A. 2021-10-26 /pmc/articles/PMC8576520/ /pubmed/34764872 http://dx.doi.org/10.3389/fphar.2021.753676 Text en Copyright © 2021 Ye, Mao, Xie, Zhang, Liu, Peng, Yang, Li and Yuan. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Ye, Jiahui
Mao, Longfei
Xie, Luoyijun
Zhang, Rongjun
Liu, Yulin
Peng, Lizeng
Yang, Jianxue
Li, Qingjiao
Yuan, Miaomiao
Discovery of a Series of Theophylline Derivatives Containing 1,2,3-Triazole for Treatment of Non-Small Cell Lung Cancer
title Discovery of a Series of Theophylline Derivatives Containing 1,2,3-Triazole for Treatment of Non-Small Cell Lung Cancer
title_full Discovery of a Series of Theophylline Derivatives Containing 1,2,3-Triazole for Treatment of Non-Small Cell Lung Cancer
title_fullStr Discovery of a Series of Theophylline Derivatives Containing 1,2,3-Triazole for Treatment of Non-Small Cell Lung Cancer
title_full_unstemmed Discovery of a Series of Theophylline Derivatives Containing 1,2,3-Triazole for Treatment of Non-Small Cell Lung Cancer
title_short Discovery of a Series of Theophylline Derivatives Containing 1,2,3-Triazole for Treatment of Non-Small Cell Lung Cancer
title_sort discovery of a series of theophylline derivatives containing 1,2,3-triazole for treatment of non-small cell lung cancer
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8576520/
https://www.ncbi.nlm.nih.gov/pubmed/34764872
http://dx.doi.org/10.3389/fphar.2021.753676
work_keys_str_mv AT yejiahui discoveryofaseriesoftheophyllinederivativescontaining123triazolefortreatmentofnonsmallcelllungcancer
AT maolongfei discoveryofaseriesoftheophyllinederivativescontaining123triazolefortreatmentofnonsmallcelllungcancer
AT xieluoyijun discoveryofaseriesoftheophyllinederivativescontaining123triazolefortreatmentofnonsmallcelllungcancer
AT zhangrongjun discoveryofaseriesoftheophyllinederivativescontaining123triazolefortreatmentofnonsmallcelllungcancer
AT liuyulin discoveryofaseriesoftheophyllinederivativescontaining123triazolefortreatmentofnonsmallcelllungcancer
AT penglizeng discoveryofaseriesoftheophyllinederivativescontaining123triazolefortreatmentofnonsmallcelllungcancer
AT yangjianxue discoveryofaseriesoftheophyllinederivativescontaining123triazolefortreatmentofnonsmallcelllungcancer
AT liqingjiao discoveryofaseriesoftheophyllinederivativescontaining123triazolefortreatmentofnonsmallcelllungcancer
AT yuanmiaomiao discoveryofaseriesoftheophyllinederivativescontaining123triazolefortreatmentofnonsmallcelllungcancer